Targeted Therapy of Advanced Gallbladder Cancer and Cholangiocarcinoma with Aggressive Biology: Eliciting Early Response Signals from Phase 1 trials

PURPOSE: Patients with advanced cholangiocarcinoma (CC) and gallbladder carcinoma (GC) have few therapeutic options for relapsed disease. METHODS: Given the overall poor prognosis in this population and the availability of novel targeted therapies, we systematically analyzed the characteristics and...

Descripción completa

Detalles Bibliográficos
Autores principales: Subbiah, Ishwaria M., Subbiah, Vivek, Tsimberidou, Apostolia M., Naing, Aung, Kaseb, Ahmed O., Javle, Milind, Fu, Siqing, Hong, David S., Piha-Paul, Sarina, Wheler, Jennifer J., Hess, Kenneth R., Janku, Filip, Falchook, Gerald S., Wolff, Robert A, Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2013
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702215/
https://www.ncbi.nlm.nih.gov/pubmed/23391555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702215/
https://www.ncbi.nlm.nih.gov/pubmed/23391555

Ejemplares similares